US 12,285,738 B2
Modulation of glucose bioaccessibility with superabsorbent materials
Lijun Sun, La Canada Flintridge, CA (US)
Filed by SIMEON INVESTMENT, INC., Arcadia, CA (US)
Filed on Aug. 12, 2021, as Appl. No. 17/401,179.
Application 17/339,416 is a division of application No. 16/807,004, filed on Mar. 2, 2020, granted, now 11,045,786.
Application 17/401,179 is a continuation in part of application No. 17/339,416, filed on Jun. 4, 2021, granted, now 11,911,744.
Application 16/807,004 is a continuation of application No. PCT/US2019/046077, filed on Aug. 10, 2019.
Claims priority of provisional application 62/717,644, filed on Aug. 10, 2018.
Prior Publication US 2021/0370269 A1, Dec. 2, 2021
Int. Cl. B01J 20/24 (2006.01); A61K 31/736 (2006.01); B01J 20/30 (2006.01)
CPC B01J 20/24 (2013.01) [A61K 31/736 (2013.01); B01J 20/3021 (2013.01); B01J 20/3078 (2013.01)] 19 Claims
 
1. A method for reducing glucose bioaccessibility in a subject, comprising administering to the subject an effective amount of a superabsorbent material having a porous network structure without any chemical cross-linking; wherein the superabsorbent material is a dehydrated gel comprising agar, carrageenan, and konjac gum; and wherein the superabsorbent material has an absorption ratio of at least 10 in deionized water at 25° C.